Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate panel approves pharmacy rule rewrite but removes state compounding labeling language
Summary
The Senate Health and Welfare Committee approved a broad rewrite of Idaho Board of Pharmacy rules but voted to strike specific state labeling language for distributed compounded drug products amid stakeholder concern and federal uncertainty.
The Senate Health and Welfare Committee voted to approve a comprehensive rewrite of Idaho State Board of Pharmacy rules (docket 24-3601-2402) on a motion that removed a narrow compounding-labeling provision after committee members raised concerns about regulatory conflict with unsettled federal guidance.
The committee earlier took no action on the temporary rule docket (24-3601-2401), allowing those temporary rules to expire. That motion was moved by Senator Harris and seconded by Senator Wintrow and carried on voice vote.
Why it matters: The pending rule package is a broad “zero-based review” (ZBR) rewrite intended to remove duplicative or outdated text from pharmacy rules after legislative changes (House Bill 527 was cited as moving several provisions to statute). Committee debate focused on a subsection in the pending chapter that sets state…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
